(1-5-22) Lisa Dailey, Executive Director of The Treatment Advocacy Center, answered the same four questions that I posed to Dr. Delphin-Rittmon, Assistant Secretary for Mental Health and Substance Abuse, and other mental health leaders at the start of the new year. Thank you Director Dailey for your responses.
Question One: What was Treatment Advocacy Center’s biggest accomplishment during 2021?
The second year of the pandemic presented a new and unprecedented challenge to our commitment to represent those with the most severe mental illness in every relevant conversation.
In a normal year, we know what this encompasses. In 2021, research began to demonstrate something very concerning: our specific population, and particularly those with schizophrenia, are at a much higher risk of death or severe illness due to COVID than any other population apart from the elderly. It wasn’t a modest effect. The data was absolutely clear that failure to prioritize vaccination for those with SMI in our public health response meant that many of our loved ones with SMI would literally die. We knew it wouldn’t be enough for people to simply be eligible for the vaccine; those most at risk did not know that they were at greater risk.
We were not seeing any efforts to acknowledge and address the unique hurdles to vaccination faced by those with severe mental illness.